StonvexLoading…
StonvexCore line items from GFF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.52B | $2.62B | $2.69B | $2.85B |
Operating Income | $206.28M | $398.30M | $196.89M | $-189.07M |
Net Income | $51.11M | $209.90M | $77.62M | $-191.56M |
EPS (Diluted) | $1.09 | $4.23 | $1.42 | $-3.71 |
Total Assets | $2.06B | $2.37B | $2.42B | $2.82B |
Total Liabilities | $1.99B | $2.15B | $2.10B | $2.34B |
Cash & Equivalents | $99.05M | $114.44M | $102.89M | $120.18M |
Free Cash Flow OCF − CapEx | $305.00M | $311.64M | $368.16M | $16.75M |
Shares Outstanding | 46.35M | 48.30M | 53.06M | 57.06M |